Skip to main content

No Successful Malpractice Case Tied to Active Surveillance of Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on April 3, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, April 2, 2024 -- To date, there is no evidence of successful malpractice litigation for active surveillance (AS) in cancer, according to a study published in the April issue of the Annals of Surgery.

Samuel Chang, J.D., from Athene Law LLP in San Francisco, and colleagues characterized malpractice trends related to AS as a treatment strategy across cancers (thyroid cancer, prostate cancer, kidney cancer, breast cancer, or lymphoma). The analysis included AS-related malpractice cases identified from the Westlaw Edge and LexisNexis Advance databases (1990 to 2022).

The researchers identified five malpractice cases tied to AS, all involving prostate cancer. Two cases involved alleged deliberate indifference from an AS management strategy but were ruled as following the appropriate standard of care. Three cases with complications from surgery alleged physician negligence for not explicitly recommending AS as a treatment option. All cases showed documented informed consent for AS, leading to defense verdicts in favor of the physicians.

"Given the legal precedent detailed in the identified cases and increasing support across national guidelines, active surveillance represents a sound management option in appropriate low-risk cancers, with no increased risk of medicolegal exposure," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Read this next

Researchers Compare Race-Based, Race-Neutral Lung Function Equations

TUESDAY, May 21, 2024 -- The use of race-based and race-neutral equations for lung-function testing generate similarly accurate predictions of respiratory outcomes, but differ in...

Survival Benefit for Cancer Trial Participants Does Not Persist in Adjusted Analyses

TUESDAY, May 21, 2024 -- In studies using designs addressing sources of bias and confounding, there is no evidence of a survival benefit for cancer trial participants, according...

Genital Talc Use Positively Linked to Ovarian Cancer

TUESDAY, May 21, 2024 -- There is a positive association between use of intimate care products, including genital talc, and ovarian cancer, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.